NASDAQ: PPBT
Purple Biotech Ltd Stock Ownership - Who owns Purple Biotech?

Insider buying vs selling

Have Purple Biotech Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PPBT insiders and whales buy or sell their stock.

PPBT Shareholders

What type of owners hold Purple Biotech Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Susquehanna International Group LLP0.05%469,767$232.53kInstitution
Two Sigma Investments LP0.02%155,353$76.90kInstitution
Smartharvest Portfolios LLC0.01%47,454$23.49kInstitution
Citadel Advisors LLC0.00%42,737$21.15kInstitution
Bnp Paribas Financial Markets0.00%21,075$10.43kInstitution
Two Sigma Advisers LP0.00%14,700$7.28kInstitution
Simplex Trading LLC0.00%9,231$4.57kInstitution
Rhumbline Advisers0.00%7,392$3.66kInstitution
Morgan Stanley0.00%6,091$3.02kInstitution
Ubs Group Ag0.00%3,098$1.53kInstitution

1 of 2

PPBT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PPBT0.09%0.00%
ESLA2.65%78.52%
IBO1.38%2.54%Net Selling
NERV40.98%59.02%
CRVO3.05%96.95%Net Buying

Purple Biotech Stock Ownership FAQ

Who owns Purple Biotech?

Purple Biotech (NASDAQ: PPBT) is owned by 0.09% institutional shareholders, 0.00% Purple Biotech insiders, and 99.91% retail investors. Susquehanna International Group LLP is the largest individual Purple Biotech shareholder, owning 469,767.00 shares representing 0.05% of the company. Susquehanna International Group LLP's Purple Biotech shares are currently valued at $232.53k.

If you're new to stock investing, here's how to buy Purple Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.